A Pseudotumor - 25/10/22
Doi : 10.1016/j.amjmed.2022.05.005
Jennifer Tat, MD, MSc a, 1, Jane Plitman, MD b, ⁎, 1 
, Wayne L. Gold, MD b, c, d
, Wayne L. Gold, MD b, c, d a Department of Pathobiology and Laboratory Medicine, University of Toronto, Ont, Canada
b Department of Medicine, University of Toronto, Ont, Canada
c Division of Infectious Diseases, University Health Network, Toronto, Ont, Canada
d Division of General Internal Medicine, University Health Network, Toronto, Ont, Canada
⁎Requests for reprints should be addressed to Jane Plitman, MD, Temerty Faculty of Medicine, University of Toronto, 200 Elizabeth Street, 13EN-213, Toronto, ON M5G 2C5, CanadaTemerty Faculty of MedicineUniversity of Toronto200 Elizabeth Street, 13EN-213TorontoONM5G 2C5Canada
Thomas J. Marrie, MD, Section Editor
Le texte complet de cet article est disponible en PDF.Plan
| Funding: None. |
|
| Conflicts of Interest: None. |
|
| Authorship: All authors had a role in writing the manuscript. WLG conceptualized the article, JT and JP drafted the initial manuscript, and all authors contributed to the writing and revision of the manuscript. |
© 2022
Elsevier Inc. Tous droits réservés.
Vol 135 - N° 11
P. 1320-1325 - novembre 2022 Retour au numéro
Article précédent
- Impact of Real-Time Benefit Tools on Patients’ Access to Medications: A Retrospective Cohort Study
- Shiven Bhardwaj, Jessica W. Merrey, Martin A. Bishop, Hsin-Chieh Yeh, Jeremy A. Epstein
- Generalized Bullous Fixed Drug Eruption to Iodinated Contrast Media in Skin of Color
- Denise Ann Tsang, Shi Yu Derek Lim, Wong Soon Boon Justin, Laura Li Yao Hui
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?